About 100 reports

  • Description of Brain Cancer Types
  • 3.5.1 Diagnosed Incident Cases of Brain Cancer

Brain Cancer: Epidemiology Forecast to 2027 Summary Epidemiologists forecast that the diagnosed incident cases of brain cancer will increase from 119,717 cases in 2017 to 151,067 cases in 2027, at an Annual Growth Rate (AGR) of 2.62% in the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and urban...

  • Brain Cancer
  • United Kingdom
  • United States
  • World
  • Forecast

You can request one free hour of our analyst’s time when you purchase this market report.

  • Brain Cancer
  • World
  • Market Size

Global Brain Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Brain Cancer
  • Cancer
  • United States
  • World
  • Forecast

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • France
  • United States
  • Market Size

Europe Brain Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Brain Cancer
  • Europe
  • France
  • Germany
  • Forecast

EpiCast Report: Brain Cancer - Epidemiology Forecast to 2024 ## Table of Contents ## Table of Contents ## ##. ## List of Tables ## ##. ## List of Figures ## ## Introduction ## ##. ## Catalyst ## ##. ## Related Reports ## ##. ## Upcoming Reports ## ## Epidemiology ## ##. ## Disease Background ##

  • Brain Cancer
  • Cancer
  • United States
  • World
  • Forecast

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • France
  • Germany
  • Italy
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Japan
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • United States
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • United Kingdom
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Italy
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • France
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Germany
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Spain
  • Market Size
  • Brain Cancer Treatment Drugs Sales Volume
  • Brain Cancer Treatment Drugs Sales Volume by Drugs Classification in 2017(percent)

China’s demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Brain Cancer
  • China
  • Demand
  • ACON Biotech Co., Ltd
  • Bayer Schering Pharmaceutical Co., Ltd
  • Chapter IV
  • Pricing Trend

Some brain cancers occur when one type of cell transforms from its normal characteristics.

  • Brain Cancer
  • China
  • Demand
  • ACON Biotech Co., Ltd
  • Beijing Novartis Pharma Ltd
  • Brain Cancer Treatment Drugs Sales Volume by Drugs Classification in 2017(percent)
  • Market Size

This study focuses on China’s Brain Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Brain Cancer
  • China
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Nov 21, 2017: Cure Brain Cancer Foundation: 2017 Grant Recipients Announced

Summary University Of Queensland (UQ) is a research institute.The university manages personal, career, welfare and learning issues. It conducts research in the areas of physical sciences, biological sciences, technology, biomedical and clinical health sciences, engineering, chemical sciences and environmental sciences,...

  • Brain Cancer
  • Healthcare
  • Pharmaceutical
  • Australia
  • Agilent Technologies, Inc.

Increasing prevalence of cancer, brain tumours, and renal cell cancer will boost the market growth.

  • Brain Cancer
  • North America
  • United States
  • World
  • Guerbet Group
  • DESCRIPTION OF BRAIN CANCER TYPES
  • 4.5 EPIDEMIOLOGICAL FORECAST FOR BRAIN CANCER (2014-2024)

Opportunity Analyzer: Glioblastoma - Opportunity Analysis and Forecasts to 2024 Summary Glioblastoma multiforme (GBM) is characterized as a disease with some of the highest unmet needs in oncology, with patients having a median overall survival (OS) of between one and two years. The lack of therapies is primarily...

  • Brain Cancer
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Celldex Therapeutics, Inc.
  • Tocagen Inc.
  • LATEST CLINICAL TRIALS NEWS ON BRAIN CANCER
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF BRAIN CANCER TO ONCOLOGY CLINICAL TRIALS

Brain Cancer Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Brain Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Brain Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cancer. Report includes an overview...

  • Brain Cancer
  • Oncology
  • United States
  • World
  • Product Initiative

Strategic initiatives List of Tables ##.

  • Brain Cancer
  • Therapy
  • United States
  • Forecast
  • Market Size
  • 18.1 Competitive Scenario
  • 05. Introduction

Introduction Glioblastoma multiforme is a variant of brain cancer, and is one of the most aggressive diseases.

  • Brain Cancer
  • Arbor Pharmaceuticals, LLC
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche Ltd.

Brain Cancer Pipeline Highlights – 2017 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • United States
  • Product Initiative
  • Brain Cancer - Dormant Projects
  • Brain Cancer - Discontinued Products

Brain Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H2 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain Cancer, complete with comparative analysis...

  • Brain Cancer
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Exelixis, Inc.
  • NANOTHERM - BRAIN CANCER
  • NANOTHERM - BRAIN CANCER PRODUCT OVERVIEW

Summary MagForce AG (MagForce) is a medical device company that offers nanotechnology-based therapy for cancer treatment.The company’s products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. Its NanoActivator creates a magnetic field that can be used to treat tumors in all areas of the body.MagForce’s...

  • Brain Cancer
  • Therapy
  • United States
  • Product Initiative
  • MagForce AG
  • JUN 23, 2015: CELLMID COLLABORATION TO TREAT BRAIN CANCER
  • OCT 05, 2016: CELLMID'S MIDKINE ANTIBODIES SHOW ANTI-TUMOR ACTIVITY AGAINST BRAIN CANCER

Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Pipeline Review, H2 2017 Summary Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Midkine (MDK) or neurite growth-promoting...

  • Brain Cancer
  • World
  • Litigation And Patent
  • Product Initiative
  • Cellmid Limited
  • JUN 13, 2018: IMMUNOTHERAPY VACCINE SHOWS GREAT PROMISE IN TREATING BRAIN CANCER PATIENTS
  • SL-701 - DRUG PROFILE

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H2 2018 Summary Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) pipeline Target constitutes close to 21 molecules....

  • Brain Cancer
  • Oncology
  • United States
  • Product Initiative
  • Immunovaccine Inc.
  • Oct 12, 2017: Lenox Hill Hospital participates in clinical research study to test investigational treatment for recurrent brain cancer

Summary Cantex Pharmaceuticals Inc (Cantex Pharmaceuticals), formerly ParinGenix Inc is a clinical stage biopharmaceutical company.The company discovers and develops proprietary pharmaceuticals for the treatment of cancers and other disorders. Its pipeline products include CX-01 a proprietary combination of disulfiram...

  • Brain Cancer
  • United States
  • Deals & Alliance
  • Product Initiative
  • Cantex Pharmaceuticals, Inc.
  • Sep 26, 2016: Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
  • Nov 27, 2017: Cancer drug starts clinical trials in human brain-cancer patients

Anaplastic Astrocytoma - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Astrocytoma - Pipeline Review, H1 2018, provides an overview of the Anaplastic Astrocytoma (Oncology) pipeline landscape. Anaplastic astrocytoma...

  • Brain Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative